fda tirzepatide shortage update today confirms is still over, gives compounders a grace period The Tirzepatide Shortage Is Over:

9,353,354,355 Specifically, the increased gluconeogenesis and decreased glycogen synthesis in hepatic IR results in fasting hyperglycemia that increases total TG levels and blood pressure (BP), reduces HDL-C levels, and increases the risk of thrombosis formation

These do not interact with GLP-1 pathways

Sources Sikiric P, Rucman R, Turkovic B, et al

With that said, semaglutide is not a medication to treat liver concerns and does not replace those medications

They are available only as research peptides through suppliers such as Pure Peptides UK , specifically for laboratory and preclinical studies

It's barebones, certainly, but the spartan layout facilitates navigation